CA2 and multiple sclerosis: van Oosten BW, Barkhof F, Truyen L et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti‐tumor necrosis factor antibody cA2. Neurology 1996;47:1531–4.